![]() |
Volumn 98, Issue 10, 2013, Pages
|
The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia
|
Author keywords
Bleeding; Chronic myeloid leukemia; Ponatinib
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
DABIGATRAN;
ENOXAPARIN;
PONATINIB;
PRASUGREL;
RIVAROXABAN;
WARFARIN;
BCR ABL PROTEIN;
IMIDAZOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDAZINE DERIVATIVE;
BLEEDING;
CHRONIC MYELOID LEUKEMIA;
EPISTAXIS;
HEMATOMA;
HEMATURIA;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MENORRHAGIA;
RECTUM HEMORRHAGE;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
VAGINA BLEEDING;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
DRUG RESISTANCE;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
PATHOLOGY;
THROMBOCYTE;
BLOOD PLATELETS;
DRUG RESISTANCE, NEOPLASM;
FUSION PROTEINS, BCR-ABL;
HUMANS;
IMIDAZOLES;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
PROTEIN KINASE INHIBITORS;
PYRIDAZINES;
|
EID: 84884933807
PISSN: 03906078
EISSN: 15928721
Source Type: Journal
DOI: 10.3324/haematol.2013.091678 Document Type: Letter |
Times cited : (8)
|
References (5)
|